Cory Kasimov
Stock Analyst at Evercore ISI Group
(0.79)
# 2350
Out of 5,372 analysts
97
Total ratings
46.51%
Success rate
-7.33%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
XENE Xenon Pharmaceutical... | Initiates Coverage On: Outperform | 55 | 31.89 | 72.47% | 1 | May 14, 2025 | |
MRNA Moderna | Maintains: In-Line | 50 32 | 26.18 | 22.23% | 6 | May 2, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Outperform | 190 185 | 124.03 | 49.16% | 2 | Apr 24, 2025 | |
SMMT Summit Therapeutics | Initiates Coverage On: Outperform | 30 | 19.73 | 52.05% | 1 | Mar 12, 2025 | |
SWTX SpringWorks Therapeu... | Maintains: Outperform | 60 65 | 46.88 | 38.65% | 2 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 50 | 40.32 | 24.01% | 3 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 50 | 14.86 | 236.47% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 110 125 | 105.3 | 18.71% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 115 105 | 55.89 | 87.87% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1250 1175 | 520.56 | 125.72% | 5 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 85 | 64.18 | 32.44% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 88 | 36.7 | 139.78% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 260 250 | n/a | n/a | 2 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | n/a | n/a | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 324 276 | 129.45 | 113.21% | 3 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 2.71 | 1191.51% | 1 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1520 780 | n/a | n/a | 3 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 232 | 294.75 | -21.29% | 5 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 168 163 | n/a | n/a | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | 29.85 | -29.65% | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 83 23 | 3.47 | 562.82% | 6 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 71 16 | n/a | n/a | 8 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 63 | n/a | n/a | 5 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 110 | n/a | n/a | 2 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 15 10 | 0.71 | 1308.45% | 1 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 310 250 | 10.15 | 2363.05% | 1 | Feb 14, 2018 |